Research · Sep 3, 2026
[ARCC] Ares Capital Thesis 2026: Record Portfolio Deployed as BDC Delivers Consistent Double-Digit ROE
Ares Capital Corporation FY25 revenue $3.15B (+33%); op income $2.19B (+37%); NI $1.30B (-15% from FY24 elevated mark gains); EPS $1.86 (-24%). FCF $1.14B (-11%). Core EPS Q4 $0.50 / FY $2.01. Total new commitments 2025 reached $15.8B — new annual record. Portfolio at fair value ended Q4 at $29.5B, up from prior periods. Core EPS fully covered dividends and drove ROE in excess of 10% for both Q4 and full year. Rebound in transaction activity H2 2025 led to meaningful acceleration in new investment commitments. Specialized industry verticals (sports media, specialty healthcare, others) saw non-sponsored originations grow over 50%. Portfolio company performance: weighted average organic EBITDA growth over 3 times GDP; average portfolio leverage decreased; interest coverage ratio improved to 2.2 times. Credit quality stable; non-accruals in line; pretax net realized gains on investments >$100M FY25. Total debt $15.99B (+16%). FY26 framework: expect ~$0.10/share earnings headwind from decline in base rates; Q1 2026 dividend $0.48/share payable March 31; strong start with $1.4B+ commitments through January 29, 2026; backlog $2.2B (+17% vs prior period); confidence in maintaining dividend with spillover income cushion. Risks: base rate environment, credit cycle dynamics, competition (Apollo, Blackstone, KKR, Blue Owl, Golub, Antares, Audax), sponsor PE deal cycle, regulatory (BDC), spread compression.